Skip to main content
. 2018 Jan 18;146(3):339–344. doi: 10.1017/S0950268817003016

Table 3.

Drug resistance to PIs in the patients

ATV DRV FPV IDV LPV/r NFV SQV TPV
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
P 14 (1.50) 0 17 (1.82) 14 (1.50) 15 (1.61) 7 (0.75) 0 11 (1.18)
L 0 0 0 1 (0.11) 0 14 (1.50) 1 (0.11) 4 (0.43)
I 0 0 0 0 0 2 (0.21) 0 0
H 1 (0.11) 0 0 0 0 1 (0.11) 0 0
Drug resistance 1 (0.11) 0 0 1 (0.11) 0 17 (1.82) 1 (0.11) 4 (0.43)

P, potential resistance; L, low resistance; I, intermediate resistance; H, high resistance.

ATV, atazanavir; DRV, darunavir; FPV, fosamprenavir; IDV, indinavir; LPV/r, kaletra; NFV, nelfinavir; SQV, saquinavir; TPV, tipranavir.

Drug resistance=L+I+H.